Adult Epilepsy Program
  Pediatric Epilepsy
  Adult Neurooncology

Pediatric Neurooncology

  Adult Spasticity
  Pediatric Spasticity

Craniofacial Disorders

Movement Disorders

Neurosurgical Pain Management

Neurovascular Compression Syndromes

  Peripheral Nerve Surgery and Brachial Plexus Repair

Skull Base Surgery

Spina Bifida

   

 
 

Neurovascular Compression Syndromes

  Overview
  Participants
  More on Hemifacial Spasm
  More on Trigeminal Neuralgia

 
 

Hemifacial Spasm

Hemifacial spasm is a unique facial movement disorder characterized by unilateral involuntary contractions of the facial muscles. It often begins with the muscles around the eye, but with time will spread to involve the muscles of the cheek and even the superficial muscles of the neck. The contractions are intermittent, sudden and unexpected. They may follow one upon the other and produce a nearly continuous facial contraction but there are generally long periods during which the contractions are minimal or absent.

Hemifacial spasm is easily distinguished from blepharospasm because of its unilateral nature and because the contractions tend to be coarser and more intermittent. It must be distinguished from a continuous, undulating, small magnitude contractions of facial myokymia. Sometimes the most difficult distinction is from habit tics. These facial movements can simulate hemifacial spasm but will never be seen during sleep and are generally more stereotyped than hemifacial spasm.

Hemifacial spasm is painless. Over time, some weakness of the face on the side of the spasm may develop. A degree of continuous contraction, or tonus, may be found in long standing cases. If there is continuing damage to the facial nerve, muscles in different parts of the face on the involved side may begin to contract simultaneously, a condition known as synkinesis.

The cause of hemifacial spasm is unknown. However, the fact that removing pressure on the facial nerve near the point where it leaves the brain very frequently relieves the spasm suggests that such pressure is the case of the spasm.

Treatment for hemifacial spasm runs the range of benign neglect to major surgery. It is important to remember that hemifacial spasm is not a dangerous or life threatening disease. It does cause obvious deformity of the face and can be quite embarrassing and interfere with a persons social interactions. As it becomes more advanced, involuntary eye closure at times of stress concentration, such as when reading or driving, can significantly interfere with a person's functioning. Therefore, many people with hemifacial spasm choose to have it treated.

Medical treatment. Sometimes, physicians will attempt to treat hemifacial spasm with medication. The most effective medication is carbomazepine (also known as Tegretol). Although highly effective for a similar problem producing intermittent facial pain called trigeminal neuralgia, Tegretol is only rarely effective in the long run for hemifacial spasm. In many cases it is not effective at all. Related medications such as phenytoin and baclofen may be tried, but are even less effective. Sedatives and muscle relaxants such as diazepam (Valium) and clonazepam (Klonopin) are occasionally useful in the treatment of hemifacial spasm.

Botulinum Toxin. For patients with mild spasm restricted to one part of the face who are willing to have repeated treatments or for those too ill to undergo surgery, botulinum toxin injections can effectively eliminate the spasm for a period of several months. Because of the number of injections that would be required and a limitation on the total dose of toxin that can be injected, it is generally not practical to treat the entire face. Repeat injections every 3-6 months are usually required. Botulinum toxin is an effective means of achieving partial, temporary control of hemifacial spasm. For a person whose primary concern is to reduce spasm around the eye to allow reading and binocular vision while driving, it may be the most desirable form of treatment. It is not, however, curative and the young or severely involved patient will want to give serious consideration to surgical treatment.

Surgical treatment. Historically, surgical treatment involved partial or complete damage to the facial nerve. Spasm would be eliminated by causing weakness. If the nerve was only partially damaged, as it recovered and facial strength returned, the spasm would return. This situation changed in the 1950's when a neurosurgeon in Cleveland, William Gardner, documented cases of hemifacial spasm associated with bulging from arteries near the point where the nerve leaves the brain. Relieving the pressure that these bulging arteries put on the facial nerve relieved the spasm. This concept was refined and popularized in the 1970's by Dr. Peter Jannetta of Pittsburgh. He demonstrated that even normal arteries pushing on the facial nerve where it leaves the brain were associated with hemifacial spasm. When these arteries were moved away from the nerve, the spasm would go away. This operation is called "microvascular decompression". It is now considered to be the definitive treatment for hemifacial spasm and is curative in 80% or more of patients who have the operation.

As currently practiced, microvascular decompression is performed through a quarter sized opening in the skull just behind the ear. The membranes surrounding the brain and holding in the spinal fluid are opened, spinal fluid removed and the nerve exposed. Using a surgical microscope to magnify the region, the small artery or arteries pushing on the nerve are identified and moved away from the nerve. A small piece of shredded teflon felt which looks like cotton is used to hold the arteries in their new position. During the operation, the function of the facial nerve is electronically monitored. The abnormal contractions can be seen in most patients and disappear immediately when the decompression is completed. Such monitoring guides the surgeon and increases the chance of a successful operation. After the decompression is completed the membranes are sewn back together, the removed bone is replaced (often with a plastic plate) and the skin is closed.

A typical patient is in the hospital for 3-7 days after surgery, the patient's age being the best predictor of how long they will stay. It is a matter of 2-6 weeks before the person has regained normal levels of energy and functioning.

The operation of microvascular decompression has been curative in over 80% of the patients who it is performed. Some patients experience recurrence of the spasm which goes away on its own and some have required reoperation or have elected to have secondary treatment with botulinum toxin. The operation has been a safe one in experienced hands. Nonetheless, it is major surgery near critical parts of the brain and serious complications including stroke and even death can and have occurred. The most common complications, however, are not life threatening. Five to 7% of patients will experience some permanent decrease in hearing on the side of the operation. This is because the nerve for hearing lies right next to the facial nerve and is very sensitive to any manipulation. Spinal fluid leakage occurs in 5-15% of patients. While this creates a risk for infection or meningitis, it generally can be successfully treated without additional surgery and merely prolongs the hospital stay.

For those patients who desire a permanent solution to their problem with hemifacial spasm microvascular decompression is the obvious choice. The small risks of serious complications must be weighed against the degree of interference with the person's daily functioning in making a decision regarding surgical treatment. While many patients who undergo microvascular decompression after having a series of botulinum toxin injections ask "Why didn't I have this done right away?", others will choose to stay with a series of botulinum toxin injections in order to avoid the discomfort and risk of microvascular decompression. This is a very individual decision that should be discussed thoroughly with physicians knowledgeable and experienced with both types of treatment.

For questions or further information Doctor Patel can be contacted at:

Department of Neurological Surgery
Medical University of South Carolina
(843) 792-9782

[contact us]